spacer
spacer

PDBsum entry 6tq7

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Membrane protein PDB id
6tq7

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
301 a.a.
Ligands
NVK ×4
SO4 ×3
SOG ×11
PGW ×2
Waters ×19
PDB id:
6tq7
Name: Membrane protein
Title: Crystal structure of the orexin-1 receptor in complex with sb-334867
Structure: Orexin receptor type 1. Chain: a, b. Synonym: ox1r,hypocretin receptor type 1. Engineered: yes. Mutation: yes. Other_details: sb-334867 bound in the orthosteric site
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: hcrtr1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
Resolution:
2.66Å     R-factor:   0.222     R-free:   0.255
Authors: M.Rappas,A.Ali,K.A.Bennett,J.D.Brown,S.J.Bucknell,M.Congreve, R.M.Cooke,G.Cseke,C.De Graaf,A.S.Dore,J.C.Errey,A.Jazayeri, F.H.Marshall,J.S.Mason,R.Mould,J.C.Patel,B.G.Tehan,M.Weir, J.A.Christopher
Key ref: M.Rappas et al. (2020). Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J Med Chem, 63, 1528-1543. PubMed id: 31860301 DOI: 10.1021/acs.jmedchem.9b01787
Date:
16-Dec-19     Release date:   01-Jan-20    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
O43613  (OX1R_HUMAN) -  Orexin/Hypocretin receptor type 1 from Homo sapiens
Seq:
Struc:
425 a.a.
301 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 11 residue positions (black crosses)

 

 
DOI no: 10.1021/acs.jmedchem.9b01787 J Med Chem 63:1528-1543 (2020)
PubMed id: 31860301  
 
 
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.
M.Rappas, A.A.E.Ali, K.A.Bennett, J.D.Brown, S.J.Bucknell, M.Congreve, R.M.Cooke, G.Cseke, C.de Graaf, A.S.Doré, J.C.Errey, A.Jazayeri, F.H.Marshall, J.S.Mason, R.Mould, J.C.Patel, B.G.Tehan, M.Weir, J.A.Christopher.
 
  ABSTRACT  
 
The orexin system, which consists of the two G protein-coupled receptors OX1 and OX2, activated by the neuropeptides OX-A and OX-B, is firmly established as a key regulator of behavioral arousal, sleep, and wakefulness and has been an area of intense research effort over the past two decades. X-ray structures of the receptors in complex with 10 new antagonist ligands from diverse chemotypes are presented, which complement the existing structural information for the system and highlight the critical importance of lipophilic hotspots and water molecules for these peptidergic GPCR targets. Learnings from the structural information regarding the utility of pharmacophore models and how selectivity between OX1 and OX2 can be achieved are discussed.
 

 

spacer

spacer